March 18, 2019
Article
Clostridium difficile rates in stem cell transplant patients are approximately 9 times greater than in hospitalized patients, with rates about twice as high in allogeneic vs autologous transplants.
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot
Estrogen Treatment Reduces Risk of COVID-19 Mortality
FDA Approves Pfizer-BioNTech Booster Shot for Children 5 and Older
An Issue About COVID-19